David T Howton insider trades

Open-market stock purchases and sales by David T Howton, Chief Operating Officer at Solid Biosciences Inc, from SEC Form 4 filings since Sep 1, 2011.

Recent trades

DateStockTradeValue
Feb 18, 2026SLDB Solid Biosciences IncSold$43.5K
Feb 13, 2026SLDB Solid Biosciences IncBought (not open market)—
Feb 4, 2026SLDB Solid Biosciences IncSold$122K
Feb 2, 2026SLDB Solid Biosciences IncSold$243K
Jan 31, 2026SLDB Solid Biosciences IncBought (not open market)—
Jan 29, 2026SLDB Solid Biosciences IncBought (not open market)—
Jan 29, 2026SLDB Solid Biosciences IncBought (not open market)—
Jan 29, 2026SLDB Solid Biosciences IncBought (not open market)—
Jan 29, 2026SLDB Solid Biosciences IncBought (not open market)—
Dec 3, 2025SLDB Solid Biosciences IncSold$25.2K
Dec 2, 2025SLDB Solid Biosciences IncBought (not open market)—

Companies traded

  • SLDB Solid Biosciences Inc: 7 sales, last Feb 18, 2026
  • SRPT Sarepta Therapeutics, Inc: 16 sales, last Jun 22, 2020
  • VRTX Vertex Pharmaceuticals Inc / MA: 1 sale, last Feb 2, 2012

Get free alerts when David T Howton files a new trade →